pd 173074 has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gyanchandani, R | 1 |
| Ortega Alves, MV | 1 |
| Myers, JN | 1 |
| Kim, S | 1 |
| Kumar, SB | 1 |
| Narasu, L | 1 |
| Gundla, R | 1 |
| Dayam, R | 1 |
| J A R P, S | 1 |
1 review available for pd 173074 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Fibroblast growth factor receptor inhibitors.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Drug Design; Humans; Neoplasms; Neovascular | 2013 |
1 other study available for pd 173074 and Angiogenesis, Pathologic
| Article | Year |
|---|---|
A proangiogenic signature is revealed in FGF-mediated bevacizumab-resistant head and neck squamous cell carcinoma.
Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Carcinoma, Squamou | 2013 |